With stocks continuing to surge in 2025 (up just over 17% year-to-date), following a 23% rise in 2024 (excluding dividends), 2026 could be another bumper year. In the macroeconomic environment, there are several trends that I see continuing to play out overI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the great ...

Core Insights - The article emphasizes the importance of long-term investing, highlighting the benefits of compounding and dividend reinvesting as key strategies for wealth creation [1] - It advocates for a balanced investment approach that combines steady accumulation of high-quality assets with high-risk, high-reward opportunities and transformative technologies [1] Group 1: Investment Philosophy - The philosophy of investing is centered around the slow accumulation of high-quality assets, which is seen as essential for wealth creation [1] - The article suggests that patient investing through both good and bad market conditions yields the greatest rewards [1] Group 2: Personal Experience and Approach - The author describes themselves as an amateur investor with no formal education in investing or business, emphasizing self-education and learning from others [1] - The author has over 20 years of teaching experience at the college/university level and holds a PhD from Brunel University, indicating a strong academic background [1]

Company Overview - Medtronic plc is an American-Irish medical device and components company founded in 1949 in Minneapolis, MN [1] - The company moved its legal and executive headquarters to Dublin after acquiring Covidien in 2015 [1] Investment Philosophy - The approach to investing emphasizes the joy of compounding, the value of dividend reinvesting, and the principle of patient investing through various market conditions [1] - The strategy includes a mix of steady accumulation of high-quality assets along with high-risk/high-reward opportunities and transformative technologies [1] Personal Background - The individual behind the investment philosophy is an amateur investor with over 25 years of experience and a PhD from Brunel University [1] - The individual has been teaching at the college/university level for over 20 years and values learning from others [1]

Company Overview - Medtronic plc is an American-Irish medical device and components company founded in 1949 in Minneapolis, MN [1] - The company moved its legal and executive headquarters to Dublin after acquiring Covidien in 2015 [1] Investment Philosophy - The investment philosophy emphasizes the joy of compounding, the value of dividend reinvesting, and the principle of patient investing through various market conditions [1] - The approach combines steady accumulation of high-quality assets with high-risk/high-reward opportunities, underappreciated turnaround plays, and transformative technologies [1] Personal Background of the Investor - The investor describes themselves as an amateur, self-taught in investing with no formal education in the field [1] - They have over 20 years of teaching experience at the college/university level and hold a PhD from Brunel University [1]

Core Insights - Uber Technologies, Inc. has become a widely recognized technology company, to the extent that its name has become a verb in everyday language, indicating its significant presence in North America and beyond [1] Company Overview - Uber operates in the technology sector, focusing on ride-hailing and related services, which have transformed transportation and logistics [1] Investment Perspective - The article emphasizes the importance of patient investing and the accumulation of high-quality assets, suggesting that Uber represents a potential opportunity for long-term investors [1]

Core Insights - The article discusses the author's previous successful predictions regarding Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) share price performance based on fundamental analysis [1] - The author emphasizes the importance of patient investing and the accumulation of high-quality assets, alongside high-risk opportunities and transformative technologies [1] Company Analysis - Regeneron Pharmaceuticals has been a focus of the author's analysis, with a history of accurate predictions regarding its stock performance [1] - The author highlights the company's commitment to making a positive impact on the world through its business practices [1] Investment Philosophy - The investment approach combines steady accumulation of quality assets with high-risk, high-reward opportunities [1] - The author advocates for dividend reinvesting and the benefits of compounding over time [1]

Core Insights - Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has been previously analyzed, indicating a consistent interest in the company's performance and potential [1] - The author emphasizes the importance of patient investing and the accumulation of high-quality assets, suggesting a long-term investment strategy [1] Company Overview - Vertex Pharmaceuticals is recognized for its commitment to improving the world through its business practices, aligning with ethical investment principles [1] - The company is involved in transformative technologies, which may present high-risk, high-reward investment opportunities [1] Investment Philosophy - The investment approach combines steady accumulation of quality assets with opportunities in underappreciated turnaround plays [1] - The author advocates for dividend reinvesting as a method to enhance wealth creation over time [1]

Company Overview - Vertex Pharmaceuticals Incorporated is a leading biotechnology company based in Boston, MA, founded in 1989, and is part of the S&P 100 with an approximate market capitalization [1]. Investment Philosophy - The investment philosophy emphasizes the importance of compounding, dividend reinvesting, and patient investing through various market conditions to achieve wealth creation [1]. - The approach combines steady accumulation of high-quality assets with high-risk/high-reward opportunities, underappreciated turnaround plays, and transformative technologies [1]. Personal Background of the Investor - The investor describes themselves as an amateur, self-taught in investing without formal education, but knowledgeable in identifying credible sources of information [1]. - The investor holds a PhD from Brunel University and is an accomplished academic writer and editor, also teaching at the college/university level [1].

Core Insights - The article emphasizes the importance of patient investing and the accumulation of high-quality assets over time as a key to wealth creation [1] - It highlights the balance between steady investment strategies and high-risk, high-reward opportunities as essential for enjoying the investment process [1] - The author advocates for investing in companies and industries that contribute positively to society [1] Investment Philosophy - The investment approach focuses on the joy of compounding and the value of dividend reinvesting [1] - The principle of investing through both good and bad times is presented as a strategy that yields the greatest rewards [1] - The author identifies a mix of steady investments and transformative technologies as a way to enhance investment returns [1] Personal Background - The author describes themselves as an amateur investor with no formal education in investing or business, emphasizing self-education and learning from others [1] - The author holds a PhD from Brunel University and has experience teaching at the college/university level [1]